1. Home
  2. FGEN vs MIND Comparison

FGEN vs MIND Comparison

Compare FGEN & MIND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGEN
  • MIND
  • Stock Information
  • Founded
  • FGEN 1993
  • MIND 1987
  • Country
  • FGEN United States
  • MIND United States
  • Employees
  • FGEN N/A
  • MIND N/A
  • Industry
  • FGEN Biotechnology: Pharmaceutical Preparations
  • MIND Industrial Machinery/Components
  • Sector
  • FGEN Health Care
  • MIND Industrials
  • Exchange
  • FGEN Nasdaq
  • MIND Nasdaq
  • Market Cap
  • FGEN 34.5M
  • MIND 30.7M
  • IPO Year
  • FGEN 2014
  • MIND 1994
  • Fundamental
  • Price
  • FGEN $0.36
  • MIND $6.86
  • Analyst Decision
  • FGEN
  • MIND
  • Analyst Count
  • FGEN 0
  • MIND 0
  • Target Price
  • FGEN N/A
  • MIND N/A
  • AVG Volume (30 Days)
  • FGEN 911.8K
  • MIND 426.1K
  • Earning Date
  • FGEN 11-12-2024
  • MIND 12-10-2024
  • Dividend Yield
  • FGEN N/A
  • MIND N/A
  • EPS Growth
  • FGEN N/A
  • MIND N/A
  • EPS
  • FGEN N/A
  • MIND 6.61
  • Revenue
  • FGEN $180,015,000.00
  • MIND $45,197,000.00
  • Revenue This Year
  • FGEN $19.67
  • MIND $22.98
  • Revenue Next Year
  • FGEN N/A
  • MIND $10.18
  • P/E Ratio
  • FGEN N/A
  • MIND $1.09
  • Revenue Growth
  • FGEN 16.15
  • MIND 41.23
  • 52 Week Low
  • FGEN $0.18
  • MIND $3.05
  • 52 Week High
  • FGEN $2.93
  • MIND $7.29
  • Technical
  • Relative Strength Index (RSI)
  • FGEN 45.24
  • MIND 91.35
  • Support Level
  • FGEN $0.31
  • MIND $5.55
  • Resistance Level
  • FGEN $0.37
  • MIND $6.47
  • Average True Range (ATR)
  • FGEN 0.03
  • MIND 0.43
  • MACD
  • FGEN -0.01
  • MIND 0.34
  • Stochastic Oscillator
  • FGEN 25.66
  • MIND 95.33

About FGEN FibroGen Inc

FibroGen Inc is a biotechnology company focused on discovering, developing, and commercializing novel therapeutics to treat serious cancer biology and anemia. The Company operates in one reportable segment: the development and commercialization of novel therapeutics to treat serious unmet medical needs. The company generates the vast majority of its revenue in Europe, followed by Japan. Virtually all of FibroGen's revenue to date has been generated from its collaboration agreements. FibroGen seeks partners with research, development, and marketing capabilities and other resources that strengthen the company's ability to advance product candidates.

About MIND MIND Technology Inc. (DE)

MIND Technology Inc provides technology and solutions for exploration, survey, and defense applications in oceanographic, hydrographic, defense, seismic, and security industries. The Company operates in segments namely, Seamap Marine Products and Klein Marine Products helps manufacture and sell specialized, high-performance sonar and seismic equipment. The company generates more revenue from Seamap Marine Products. The company's geographical segments include the United States; Europe, Russia & CIS; Middle East & Africa; Asia-Pacific; and Canada & Latin America.

Share on Social Networks: